This workshop will feature experts from lung and sleep research, pulmonary critical care, and sleep medicine who will discuss gaps and opportunities within the current technologies, tools, assays, model systems, and clinical endpoints across the spectrum of acute/chronic lung diseases and sleep disorders. This event aims to facilitate advancing therapeutic leads in Investigational New Drug (IND)-enabling studies for IND application submission to the U.S. Food and Drug Administration (FDA). Participants will have the opportunity to hear from clinical trialists who have successfully navigated the IND process and advocacy groups that support the unmet needs of lung and sleep patients.
This workshop is open to the public, but registration is required. Registration closes at 5 p.m. ET on December 13, 2024. This workshop will be recorded. View the registration details through the registration link below.